154 related articles for article (PubMed ID: 36695620)
1. Improving equity in kidney transplant allocation policies through a novel genetic metric: The Matched Donor Potential.
Tambur AR; Audry B; Glotz D; Jacquelinet C
Am J Transplant; 2023 Jan; 23(1):45-54. PubMed ID: 36695620
[TBL] [Abstract][Full Text] [Related]
2. Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
Gebel HM; Kasiske BL; Gustafson SK; Pyke J; Shteyn E; Israni AK; Bray RA; Snyder JJ; Friedewald JJ; Segev DL
Clin J Am Soc Nephrol; 2016 Mar; 11(3):505-11. PubMed ID: 26839235
[TBL] [Abstract][Full Text] [Related]
3. ABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation.
Gragert L; Kadatz M; Alcorn J; Stewart D; Chang D; Gill J; Liwski R; Gebel HM; Gill J; Lan JH
Am J Transplant; 2022 Dec; 22(12):3093-3100. PubMed ID: 35975734
[TBL] [Abstract][Full Text] [Related]
4. Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation System.
Sethi S; Najjar R; Peng A; Mirocha J; Vo A; Bunnapradist S; Jordan SC; Huang E
Am J Kidney Dis; 2019 May; 73(5):605-614. PubMed ID: 30929853
[TBL] [Abstract][Full Text] [Related]
5. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
[TBL] [Abstract][Full Text] [Related]
6. Stem cell donor HLA typing improves CPRA in kidney allocation.
Kransdorf EP; Pando MJ; Stewart D; Lindblad K; Bray R; Murphey C; Kaur N; Patel JK; Kim I; Zhang X; Maiers M; Kobashigawa JA; Gragert L
Am J Transplant; 2021 Jan; 21(1):138-147. PubMed ID: 32558252
[TBL] [Abstract][Full Text] [Related]
7. Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
Heidt S; Haasnoot GW; van Rood JJ; Witvliet MD; Claas FHJ
Kidney Int; 2018 Feb; 93(2):491-500. PubMed ID: 28947279
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of HLA cross-reactive group matching on graft survival in deceased donor kidney recipients.
Lazda VA; Mozes MF
Transplant Proc; 2005 Mar; 37(2):661-3. PubMed ID: 15848493
[TBL] [Abstract][Full Text] [Related]
9. Calculated panel reactive antibody with decimals: A refined metric of access to transplantation for highly sensitized candidates.
Kransdorf EP; Pando MJ
Hum Immunol; 2017 Mar; 78(3):252-256. PubMed ID: 28069404
[TBL] [Abstract][Full Text] [Related]
10. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
[TBL] [Abstract][Full Text] [Related]
11. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.
Takemoto S; Terasaki PI; Cecka JM; Cho YW; Gjertson DW
N Engl J Med; 1992 Sep; 327(12):834-9. PubMed ID: 1508242
[TBL] [Abstract][Full Text] [Related]
12. Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies.
Tambur AR; Audry B; Antoine C; Suberbielle C; Glotz D; Jacquelinet C
Am J Transplant; 2017 Dec; 17(12):3149-3158. PubMed ID: 28597555
[TBL] [Abstract][Full Text] [Related]
13. CPRA for allocation of kidneys in the US: More candidates ≥98% CPRA, lower positive crossmatch rates and improved transplant rates for sensitized patients.
Baxter-Lowe LA; Kucheryavaya A; Tyan D; Reinsmoen N
Hum Immunol; 2016 May; 77(5):395-402. PubMed ID: 27012168
[TBL] [Abstract][Full Text] [Related]
14. Parsing the 100% calculated panel reactive antibody kidney transplant candidates: Who gets transplanted?
Keith DS
HLA; 2020 Jan; 95(1):23-29. PubMed ID: 31515960
[TBL] [Abstract][Full Text] [Related]
15. Association of Deceased Donor Acute Kidney Injury With Recipient Graft Survival.
Liu C; Hall IE; Mansour S; Thiessen Philbrook HR; Jia Y; Parikh CR
JAMA Netw Open; 2020 Jan; 3(1):e1918634. PubMed ID: 31913491
[TBL] [Abstract][Full Text] [Related]
16. Establishment of calculated panel reactive antibody and its potential benefits in improving the kidney allocation strategy in Taiwan.
Shen SW; Chang CK; Gao YS; Hsu PJ; Cheng SC; Liu FY; Lo SC
J Formos Med Assoc; 2017 Dec; 116(12):956-963. PubMed ID: 29037453
[TBL] [Abstract][Full Text] [Related]
17. Impact of the 1998 UK National Allocation Scheme for deceased heartbeating donor kidneys.
Fuggle SV; Johnson RJ; Bradley JA; Rudge CJ;
Transplantation; 2010 Feb; 89(4):372-8. PubMed ID: 20177337
[TBL] [Abstract][Full Text] [Related]
18. ABO-adjusted cPRA metric for kidney allocation in an Asian-predominant population.
Lau KM; Chu PWK; Tang LWM; Chen BPY; Yeung NKM; Ip P; Lee P; Yap DYH; Kwok JSY
HLA; 2024 Jan; 103(1):e15229. PubMed ID: 37728213
[TBL] [Abstract][Full Text] [Related]
19. New priorities: Analysis of the New Kidney Allocation System on UCLA patients transplanted from the deceased donor waitlist.
Hickey MJ; Zheng Y; Valenzuela N; Zhang Q; Krystal C; Lum E; Tsai EW; Lipshutz GS; Gritsch HA; Danovitch G; Veale J; Gjertson D; Cecka M; Reed EF
Hum Immunol; 2017 Jan; 78(1):41-48. PubMed ID: 27818166
[TBL] [Abstract][Full Text] [Related]
20. The OPTN/UNOS Renal Transplant Registry.
Cecka JM
Clin Transpl; 2005; ():1-16. PubMed ID: 17424721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
